Evidence map›Paper›PMID 41000785›Full record

ArticlebioRxiv : the preprint server for biology2025

Sequence-Independent RNA Sensing in Living Mammalian Cells.

Natalie S Kolber, K Eerik Kaseniit, Tobias V Lanz, William H Robinson, Xiaojing J Gao

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Natalie S KolberDepartment of Bioengineering, Stanford University, Stanford, CA, USA.ORCID 0000-0003-4498-9431
K Eerik KaseniitRadar Therapeutics, Emeryville, CA, USA.ORCID 0000-0002-5589-1547
Tobias V LanzInstitute for Immunity, Transplantation, and Infection, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0001-7106-8801
William H RobinsonInstitute for Immunity, Transplantation, and Infection, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0003-4385-704X
Xiaojing J GaoChEM-H Chemistry/Biology Interface Training Program, Stanford University, Stanford, CA, USA.ORCID 0000-0002-3094-1456

Funding

Deciphering the Role of Epstein-Barr Virus Molecular Mimicry and B cell Transformation in Multiple SclerosisR01AI173189 · NIAID · STANFORD UNIVERSITY · PI Tobias Volker Lanz, William H Robinson · 2023 to 2026
$2.3M
A Novel Class of Synthetic Receptors to Empower the Age of mRNA TherapiesDP2EB035891 · NIBIB · STANFORD UNIVERSITY · PI Xiaojing J Gao · 2023 to 2026
$2.3M
Cancer Classifiers Based on RNA Sensors in Living CellsR21EB033858 · NIBIB · STANFORD UNIVERSITY · PI GAO, XIAOJING J · 2022 to 2024
$619k
NIAID NIH HHS R01 AI173189NIBIB NIH HHS DP2 EB035891NIBIB NIH HHS R21 EB033858
6 · The paper itself

Abstract

Recently, several groups described sensors in living cells that take advantage of adenosine deaminases acting on RNA (ADARs) to link the presence of an RNA (a "target transcript") to the translation of a payload from a second, exogenously introduced mRNA. These sensors share the key mechanism of editing a stop codon opposite a specific sequence motif in the target transcript, where this motif requirement is dictated by ADAR's strong sequence preference. This constrains sensor design and precludes the sensing of short sequences that lack such motifs, often essential for key applications such as sensing viral RNAs and differentiating splice isoforms. Here we address this limitation with modular RNA sensors using adenosine deaminases acting on RNA ("modulADAR"). ModulADAR features two key elements that mirror the modularity of ADARs: regions that hybridize with the target transcript to recruit ADAR's dsRNA-binding domains, and a stem-loop for stop-codon editing by ADAR's catalytic domain. We optimize modulADAR and apply it to detect short subsequences that cannot be sensed by prior-generation sensors. We anticipate that modulADAR will empower broader basic science and therapeutic applications, especially those that will uniquely benefit from programmable RNA detection in living cells.

Identifiers

PMID41000785
PMCPMC12458216

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.